Last reviewed · How we verify
Fentanyl - Part A
At a glance
| Generic name | Fentanyl - Part A |
|---|---|
| Sponsor | Indivior Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Magnesium Sulfate Versus Other Anesthesia Drugs to Reduce Agitation After Adenotonsillectomy in Pediatric Patients (NA)
- The Effect Of Positive End-Expiratory Pressure on Optic Nerve Sheath Diameter In Pediatric Patients Undergoing Craniotomy in Supine Position (NA)
- Hemodynamic Effects of Fentanyl Vs Dexmedetomidine in Spine Surgery (PHASE4)
- Genicular and Anterior Femoral Cutaneous Nerve Blocks for Total Knee Arthroplasty (PHASE4)
- Minimal Flow Anesthesia and Infection Risk (NA)
- Detecting Drugs of Abuse Via Exhaled Breath Samples Using Differential Mobility Spectrometry
- Memory & Conditioning Under Anesthesia (PHASE1)
- Buprenorphine-Fentanyl Interaction Study (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fentanyl - Part A CI brief — competitive landscape report
- Fentanyl - Part A updates RSS · CI watch RSS
- Indivior Inc. portfolio CI